| The modern pre-levodopa era of Parkinson’s disease: insights into motor complications from sub-Saharan Africa R Cilia, A Akpalu, FS Sarfo, M Cham, M Amboni, E Cereda, M Fabbri, ... Brain 137 (10), 2731-2742, 2014 | 331 | 2014 |
| Neutralizing antibody and botulinum toxin therapy: a systematic review and meta-analysis M Fabbri, G Leodori, RM Fernandes, R Bhidayasiri, MJ Marti, C Colosimo, ... Neurotoxicity research 29, 105-117, 2016 | 109 | 2016 |
| Amantadine in the treatment of Parkinson's disease and other movement disorders O Rascol, M Fabbri, W Poewe The Lancet Neurology 20 (12), 1048-1056, 2021 | 106 | 2021 |
| Opicapone for the treatment of Parkinson's disease: a review of a new licensed medicine M Fabbri, JJ Ferreira, A Lees, F Stocchi, W Poewe, E Tolosa, O Rascol Movement Disorders 33 (10), 1528-1539, 2018 | 96 | 2018 |
| Do patients with late-stage Parkinson's disease still respond to levodopa? M Fabbri, M Coelho, D Abreu, LC Guedes, MM Rosa, N Costa, A Antonini, ... Parkinsonism & related disorders 26, 10-16, 2016 | 78 | 2016 |
| Speech and voice response to a levodopa challenge in late-stage Parkinson’s disease M Fabbri, I Guimarães, R Cardoso, M Coelho, LC Guedes, MM Rosa, ... Frontiers in neurology 8, 432, 2017 | 71 | 2017 |
| Substantia nigra neuromelanin as an imaging biomarker of disease progression in Parkinson’s disease M Fabbri, S Reimão, M Carvalho, RG Nunes, D Abreu, LC Guedes, ... Journal of Parkinson's disease 7 (3), 491-501, 2017 | 64 | 2017 |
| Clinical pharmacology review of safinamide for the treatment of Parkinson’s disease M Fabbri, MM Rosa, D Abreu, JJ Ferreira Neurodegenerative disease management 5 (6), 481-496, 2015 | 62 | 2015 |
| Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test M Fabbri, M Coelho, LC Guedes, I Chendo, C Sousa, MM Rosa, D Abreu, ... Parkinsonism & Related Disorders 39, 37-43, 2017 | 58 | 2017 |
| Dysphagia predicts poor outcome in late-stage Parkinson's disease M Fabbri, M Coelho, D Abreu, LC Guedes, MM Rosa, C Godinho, ... Parkinsonism & related disorders 64, 73-81, 2019 | 46 | 2019 |
| Home monitoring of motor fluctuations in Parkinson’s disease patients L Borzì, M Varrecchia, G Olmo, CA Artusi, M Fabbri, MG Rizzone, ... Journal of Reliable Intelligent Environments 5 (3), 145-162, 2019 | 43 | 2019 |
| Adjunctive therapies in Parkinson’s disease: how to choose the best treatment strategy approach M Fabbri, MM Rosa, JJ Ferreira Drugs & Aging 35, 1041-1054, 2018 | 35 | 2018 |
| Safety and efficacy of tolcapone in Parkinson’s disease: systematic review CA Artusi, L Sarro, G Imbalzano, M Fabbri, L Lopiano European Journal of Clinical Pharmacology 77, 817-829, 2021 | 32 | 2021 |
| Levodopa/carbidopa intestinal gel infusion and weight loss in Parkinson's disease M Fabbri, M Zibetti, L Beccaria, A Merola, A Romagnolo, E Montanaro, ... European Journal of Neurology 26 (3), 490-496, 2019 | 32 | 2019 |
| Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications A Merola, A Romagnolo, AK Dwivedi, A Padovani, D Berg, PJ Garcia-Ruiz, ... Journal of neurology 267, 2949-2960, 2020 | 31 | 2020 |
| COMT Inhibitors in the Management of Parkinson’s Disease M Fabbri, JJ Ferreira, O Rascol CNS drugs 36 (3), 261-282, 2022 | 30 | 2022 |
| Moving towards home-based community-centred integrated care in Parkinson's disease M Fabbri, AC Caldas, JB Ramos, Á Sanchez-Ferro, A Antonini, E Růžička, ... Parkinsonism & related disorders 78, 21-26, 2020 | 30 | 2020 |
| The late stage of Parkinson's–results of a large multinational study on motor and non-motor complications A Schrag, A Hommel, S Lorenzl, WG Meissner, P Odin, M Coelho, ... Parkinsonism & related disorders 75, 91-96, 2020 | 29 | 2020 |
| Lifestyle factors and risk for colorectal polyps and cancer at index colonoscopy in a FIT-positive screening population D Colussi, M Fabbri, RM Zagari, A Montale, F Bazzoli, L Ricciardiello United European gastroenterology journal 6 (6), 935-942, 2018 | 29 | 2018 |
| Modulation of the muscle activity during sleep in cervical dystonia E Antelmi, R Ferri, F Provini, CML Scaglione, F Mignani, F Rundo, ... Sleep 40 (7), zsx088, 2017 | 29 | 2017 |
